<DOC>
	<DOC>NCT01294215</DOC>
	<brief_summary>This is a clinical study evaluating the safety and efficacy of long term administration of oral BAYA1040_Nifedipine 80 mg/day (40 mg twice daily) with other antihypertensives in patients with essential hypertension who are not at target blood pressure by the combination of BAYA1040_Nifedipine 40 mg once daily and other antihypertensives.</brief_summary>
	<brief_title>High Dose BAYA1040_Nifedipine: a Long Term Combination Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>20 years or older Japanese male or female Outpatient with essential hypertension Patients who are treated with Adalat CR 40 mg od and at least one antihypertensive drug (other than Ca antagonists) for 4 weeks or more before entry in this study Patients whose sitting diastolic blood pressure (DBP) is 110 mm Hg or more Patients with secondary hypertension or hypertensive emergency</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>BAYA1040</keyword>
	<keyword>Nifedipine</keyword>
	<keyword>Essential hypertension</keyword>
	<keyword>Japanese Patients</keyword>
	<keyword>Phase III</keyword>
	<keyword>combination study</keyword>
	<keyword>14024</keyword>
</DOC>